Healthcare providers report unprecedented demand for reproductive and gender-affirming medications: ‘We’ve never seen this before’
When the presidential election results were handed down on Wednesday, Rebecca Gomperts, the founder of Aid Access, the No 1 supplier of abortion pills by mail in the United States, was huddled in a Paris apartment with her team of eight American physicians and 15 support staff. The group – which usually operates remotely, shipping out more than 9,000 abortion pills a month – had convened in person before the election, knowing they might have to spring into action.
They were right: as news of Trump’s victory spread, the website received more than 5,000 requests for abortion pills in less than 12 hours – a surge even larger than the day after Roe v Wade fell. “I can see all the new requests ticking in as we’re talking,” Gomperts said in a phone call on Wednesday afternoon. “We’ve never seen this before.”